Back to VRDN
CITADEL ADVISORS LLC VRDN Position History
Viridian Therapeutics, Inc. • Healthcare
Quarters held
9
Latest value
$573K
Q2 2026
Peak value
$42.8M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $42.8M |
| Q1 2026 | $2.5M |
| Q1 2026 | $1.3M |
| Q2 2026 | $759K |
| Q2 2026 | $2.6M |
| Q2 2026 | $573K |
| Q2 2026 | $759K |
| Q2 2026 | $2.6M |
| Q2 2026 | $573K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $573K | 31.2K | — | — |
| Q2 2026 | $2.6M | 139.1K | — | — |
| Q2 2026 | $759K | 41.3K | — | — |
| Q2 2026 | $573K | 31.2K | — | — |
| Q2 2026 | $2.6M | 139.1K | — | — |
| Q2 2026 | $759K | 41.3K | — | — |
| Q1 2026 | $1.3M | 64.7K | — | — |
| Q1 2026 | $2.5M | 128.4K | — | — |
| Q1 2026 | $42.8M | 2.19M | — | — |
Other funds holding VRDN
$112.5M
$112.5M
$91.4M
$46.7M